Letter to the Editor| Volume 24, ISSUE 3, P469-470, March 2002

The authors reply

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Alvarez-Requejo A
        • Carvajal A
        • Begaud B
        • et al.
        Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system.
        Eur J Clin Pharmacol. 1998; 54: 483-488
        • Bate A
        • Lindquist M
        • Edwards IR
        • et al.
        A Bayesian neural network method for adverse drug reaction signal generation.
        Eur J Clin Pharmacol. 1998; 54: 315-321
        • Whelton A
        • Fort JG
        • Puma JA
        • et al.
        Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.
        Am J Ther. 2001; 8: 85-95
        • Rothman KJ
        • Cann CI
        Judging words rather than authors.
        Epidemiology. 1997; 8 (Editorial): 223-225